COVID-19: Changing the Face of Cancer Care
The healthcare systems have shifted their attention to COVID-19. Unfortunately, patients with chronic conditions such as cancer have had to make tough decisions. MD, Chief medical officer and executive president of ASCO(American Society of Clinical Oncology) said, “ Patients undergoing cancer treatment have had to make difficult choices to interrupt or modify their cancer treatment to decrease their risk of COVID-19 but thereby increase their risk of cancer progression or to continue their cancer treatment, risking a greater likelihood of COVID-19 disease or complications.” Healthy individuals have had to postpone their screening, and newly diagnosed patients have not yet started their treatment. Clinical trials for new therapies have slowed down due to the pandemic. When COVID-19 was first reported, reports indicated that people with a weak immunity had the worse COVID-19 outcomes. However, as researchers compiled more information and results, there were varying trends. Fo